Pestell et al. found that Akt1 governs breast cancer progression: Akt1 deficiency was verified to delay tumor growth and reduce lung metastases; moreover, Akt1-deficient mammary could reduce mammary epithelial tumor cell size and proliferative capacity by reducing cyclin D1 and p27 (KIP1) expression49. Here, CCND1 is linked to neoplasm.